Lpath Inc., of San Diego, received U.S. Patent No...Nventa Biopharmaceuticals Corp., of San Diego, received U.S. Patent No...PolyMedix Inc., of Philadelphia, received U.S. Patent No

Mirus Bio Corp., of Madison, Wis., received U.S. Patent No...NanoMed Pharmaceuticals Inc., of Kalamazoo, Mich., received U.S. Patent No...ScinoPharm Taiwan Ltd., of Tainan, Taiwan, received U.S. Patent No

Endocyte Inc., of West Lafayette, Ind., received U.S. Patent No...Epix Pharmaceuticals Inc., of Lexington, Mass., received U.S. Patent No...IsoTis SA, of Irvine, Calif., was awarded U.S. Patent No

Bolder BioTechnology Inc., of Boulder, Colo., was granted U.S. Patent Nos...Cytogen Corp., of Princeton, N.J., was granted U.S. Patent No...Dyax Corp., of Cambridge, Mass., received U.S. Patent No

Adnexus Therapeutics Inc., of Waltham, Mass., received U.S. Patent No...Cephalon Inc., of Frazer, Pa., received U.S. Patent No...Targeted Genetics Corp., of Seattle, received U.S. Patent No

SemBioSys Genetics Inc., of Calgary, Alberta, was granted U.S. Patent No...Targeted Genetics Corp., of Seattle, was issued U.S. Patent No...Vical Inc., of San Diego, was issued U.S. Patent No

Ariad Pharmaceuticals Inc., of Cambridge, Mass., was issued U.S. Patent No...Arrowhead Research Corp., of Pasadena, Calif., said U.S. Patent No...EntreMed Inc., of Rockville, Md., received U.S. Patent No

4SC AG, of Martinsried, Germany, received U.S. Patent No...Alnylam Pharmaceuticals Inc., of Cambridge, Mass., was issued U.S. Patent No...AlphaVax Inc., of Research Triangle Park, N.C., was issued U.S. Patent No

Stem Cell Therapeutics Corp., of Calgary, Alberta, received U.S. Patent No...The company also received U.S. Patent No...SuperGen Inc., of Dublin, Calif., received U.S. Patent No

EntreMed Inc., of Rockville, Md., was issued U.S. Patent No...GenoMed Inc., of St. Louis, received U.S. Patent No...Introgen Therapeutics Inc., of Austin, Texas, received U.S. Patent No

DiagnoCure Inc., of Quebec City, was granted U.S. Patent No

Androclus Therapeutics Inc., of San Diego, received U.S. Patent No...Cel-Sci Corp., of Vienna, Va., received U.S. Patent No...MannKind Corp., of Valencia, Calif., received U.S. Patent No

The patent would cover immunotherapy approaches directed against the 5T4 tumor antigen...Source MDx, of Boulder, Colo., was issued U.S. Patent No

Nanosphere Inc., of Northbrook, Ill., received U.S. Patent No...NovaDel Pharma Inc., of Flemington, N.J., received U.S. Patent Nos...OncoMed Pharmaceuticals Inc., of Mountain View, Calif., was granted U.S. Patent No

MediQuest Therapeutics Inc., of Bothell, Wash., was issued U.S. Patent No...Nanogen Inc., of San Diego, received U.S. Patent No...Nanogen's subsidiary, Epoch Biosciences Inc., of Bothell, Wash., recently received U.S. Patent No

Specifically, the patent refers to the simultaneous removal of the 3'-blocks and nucleotide labels during the SBS process, providing for shorter reaction times and greater system throughput...Source MDx, of Boulder, Colo., received U.S. Patent No

Nanogen Inc., of San Diego, received U.S. Patent No...Senomyx Inc., of La Jolla, Calif., received U.S. Patent No

EntreMed Inc., of Rockville, Md., was issued U.S. Patent No...Genmab A/S, of Copenhagen, Denmark, received a patent for HuMax-HepC, a fully human antibody in preclinical development to prevent re-infection with the hepatitis C virus after liver transplantation...Mobious Genomics Ltd., of Exeter, UK, received a notice of allowance for U.S. Patent No

Stressgen Biotechnologies Corp., of San Diego, received U.S. Patent No...Targeted Genetics Corp., of Seattle, was issued U.S. Patent No...The company also was granted U.S. Patent No